Juno Therapeutics, Inc. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Juno Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Juno Therapeutics, Inc. for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | P | 36.94 | 4,054 | 149,739 | 58,000 | 53.9 K to 58 K (+7.51 %) |
Mar 30 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Buy | P | 36.22 | 3,946 | 142,923 | 53,946 | 50 K to 53.9 K (+7.89 %) |
Mar 30 2016 | JUNO | Juno Therapeutics, ... | EVNIN ANTHONY B | Director | Gift | G | 0.00 | 15,000 | 0 | 50,000 | 65 K to 50 K (-23.08 %) |
Mar 22 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 40.00 | 12,000 | 480,000 | 882,499 | 894.5 K to 882.5 K (-1.34 %) |
Mar 18 2016 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel & S ... | Sell | S | 38.47 | 1,382 | 53,167 | 60,483 | 61.9 K to 60.5 K (-2.23 %) |
Mar 18 2016 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel & S ... | Sell | S | 37.96 | 1,818 | 69,003 | 61,865 | 63.7 K to 61.9 K (-2.85 %) |
Mar 17 2016 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 10,552,390 | 11.6 M to 10.6 M (-8.66 %) |
Mar 04 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 45.00 | 5,000 | 225,000 | 730,000 | 735 K to 730 K (-0.68 %) |
Mar 03 2016 | JUNO | Juno Therapeutics, ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 39.00 | 8,600,000 | 335,400,000 | 17,166,130 | 25.8 M to 17.2 M (-33.38 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 39.88 | 43 | 1,715 | 735,000 | 735 K to 735 K (-0.01 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 39.21 | 10,076 | 395,061 | 735,043 | 745.1 K to 735 K (-1.35 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 38.18 | 6,387 | 243,863 | 745,119 | 751.5 K to 745.1 K (-0.85 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 36.82 | 900 | 33,134 | 751,506 | 752.4 K to 751.5 K (-0.12 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 36.20 | 10,581 | 382,997 | 752,406 | 763 K to 752.4 K (-1.39 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Harr Steve | See Remarks | Sell | S | 35.06 | 2,013 | 70,571 | 762,987 | 765 K to 763 K (-0.26 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Option Exercise | M | 6.36 | 54,000 | 343,440 | 893,506 | |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Sell | S | 36.46 | 3,879 | 141,421 | 2,650,609 | 2.7 M to 2.7 M (-0.15 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Sell | S | 35.27 | 86,871 | 3,063,584 | 2,654,488 | 2.7 M to 2.7 M (-3.17 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | See Remarks | Buy | M | 6.36 | 54,000 | 343,440 | 2,741,359 | 2.7 M to 2.7 M (+2.01 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Frohlich Mark W | See Remarks | Sell | S | 36.50 | 300 | 10,950 | 919,583 | 919.9 K to 919.6 K (-0.03 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Frohlich Mark W | See Remarks | Sell | S | 35.25 | 19,700 | 694,392 | 919,883 | 939.6 K to 919.9 K (-2.10 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 41.22 | 760 | 31,327 | 894,499 | 895.3 K to 894.5 K (-0.08 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 40.39 | 23,240 | 938,696 | 895,259 | 918.5 K to 895.3 K (-2.53 %) |